EXECUTIVE COMMUNICATIONS, ETC.; Congressional Record Vol. 165, No. 100
(House of Representatives - June 14, 2019)

Text available as:

Formatting necessary for an accurate reading of this text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF.


[Pages H4699-H4700]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                     EXECUTIVE COMMUNICATIONS, ETC.

   Under clause 2 of rule XIV, executive communications were taken from 
the Speaker's table and referred as follows:

       1312. A letter from the Acting Secretary, Department of 
     Defense, transmitting a letter on the approved retirement of 
     Vice Admiral Mathias W. Winter, United States Navy, and his 
     advancement to the grade of vice admiral on the retired list, 
     pursuant to 10 U.S.C. 1370(c)(1); Public Law 96-513, Sec. 112 
     (as amended by Public Law 104-106, Sec. 502(b)); (110 Stat. 
     293); to the Committee on Armed Services.
       1313. A letter from the Chairman, Appraisal Subcommittee, 
     Federal Financial Institutions Examination Council, 
     transmitting the Council's 2018 Annual Report, pursuant to 12 
     U.S.C. 3332(a)(5); Public Law 101-73, Sec. 1103 (as amended 
     by Public Law 111-203, Sec. 1473(b)); (124 Stat. 2190); to 
     the Committee on Financial Services.
       1314. A letter from the Director, Office of Legislative 
     Affairs, Federal Deposit Insurance Corporation, transmitting 
     the Corporation's final rule -- Liquidity Coverage Ratio

[[Page H4700]]

     Rule: Treatment of Certain Municipal Obligations as High-
     Quality Liquid Assets (RIN: 3064-AE77) received June 12, 
     2019, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, 
     Sec. 251; (110 Stat. 868); to the Committee on Financial 
     Services.
       1315. A letter from the President and Chief Executive 
     Officer, Federal Home Loan Bank of Pittsburgh, transmitting 
     the Federal Home Loan Bank of Pittsburgh's 2018 Statement on 
     the System of Internal Controls and 2018 audited financial 
     statements, pursuant to 31 U.S.C. 9106(a)(1); Public Law 97-
     258 (as amended by Public Law 101-576, Sec. 306(a)); (104 
     Stat. 2854); to the Committee on Oversight and Reform.
       1316. A letter from the Under Secretary, Acquisition and 
     Sustainment, Department of Defense, transmitting the 
     Department's 2018 annual Report to Congress on Defense 
     Environmental Programs, pursuant to 10 U.S.C. 2711(a); Public 
     Law 112-81, Sec. 317(a); (125 Stat. 1359); jointly to the 
     Committees on Armed Services and Energy and Commerce.
       1317. A letter from the Assistant Administrator, Diversion 
     Control Division, Drug Enforcement Administration, Department 
     of Justice, transmitting the Department's temporary amendment 
     -- Schedules of Controlled Substances: Temporary Placement of 
     5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and 
     FUB-144 into Schedule I [Docket No.: DEA-491] received June 
     12, 2019, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-
     121, Sec. 251; (110 Stat. 868); jointly to the Committees on 
     Energy and Commerce and the Judiciary.
       1318. A letter from the Assistant Administrator, Diversion 
     Control Division, Drug Enforcement Administration, Department 
     of Justice, transmitting the Department's final rule -- 
     Schedules of Controlled Substances: Placement of Furanyl 
     Fentanyl, 4-Fluoroisobutyryl Fentanyl, Acryl Fentanyl, 
     Tetrahydrofuranyl Fentanyl, and Ocfentanil in Schedule I; 
     Correction [Docket No.: DEA-490] received June 12, 2019, 
     pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 
     251; (110 Stat. 868); jointly to the Committees on Energy and 
     Commerce and the Judiciary.
       1319. A letter from the Administrative Assistant, Diversion 
     Control Division, Drug Enforcement Administration, Department 
     of Justice, transmitting the Department's final rule -- 
     Schedules of Controlled Substances: Placement of beta-
     Hydroxythiofentanyl in Schedule I [Docket No.: DEA-484] 
     received June 12, 2019, pursuant to 5 U.S.C. 801(a)(1)(A); 
     Public Law 104-121, Sec. 251; (110 Stat. 868); jointly to the 
     Committees on Energy and Commerce and the Judiciary.
       1320. A letter from the Assistant Administrator, Diversion 
     Control Division, Drug Enforcement Administration, Department 
     of Justice, transmitting the Department's notification -- 
     Chemical Names of Previously Controlled Fentanyl-Related 
     Substances [Docket No.: DEA-476] received June 12, 2019, 
     pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 
     251; (110 Stat. 868); jointly to the Committees on Energy and 
     Commerce and the Judiciary.
       1321. A letter from the Assistant Administrator, Diversion 
     Control Division, Drug Enforcement Administration, Department 
     of Justice, transmitting the Department's final rule -- 
     Control of Immediate Precursor Used in the Illicit 
     Manufacture of Fentanyl as Schedule II Controlled Substances; 
     Correction [Docket No.: DEA-305] received June 12, 2019, 
     pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 
     251; (110 Stat. 868); jointly to the Committees on Energy and 
     Commerce and the Judiciary.
       1322. A letter from the Assistant Administrator, Diversion 
     Control Division, Department of Justice, transmitting the 
     Department's final rule -- Interlocutory Appeals in 
     Administrative Hearings [Docket No.: DEA-493] received June 
     12, 2019, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-
     121, Sec. 251; (110 Stat. 868); jointly to the Committees on 
     Energy and Commerce and the Judiciary.
       1323. A letter from the Assistant Administrator, Diversion 
     Control Division, Drug Enforcement Administration, Department 
     of Justice, transmitting the Department's temporary rule -- 
     Schedules of Controlled Substances: Extension of Temporary 
     Placement of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-
     CHMICA and MDMB-FUBINACA in Schedule I of the Controlled 
     Substances Act [Docket No.: DEA-446] received June 12, 2019, 
     pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 
     251; (110 Stat. 868); jointly to the Committees on Energy and 
     Commerce and the Judiciary.
       1324. A letter from the Chief Counsel, Foreign Claims 
     Settlement Commission of the United States, Department of 
     Justice, transmitting the annual report for CY 2018 of the 
     Foreign Claims Settlement Commission of the United States, 
     pursuant to 50 U.S.C. 4107; July 3, 1948, ch. 826, Sec. 9 (as 
     amended by Public Law 89-348, Sec. 2(6)); (79 Stat. 1312) and 
     22 U.S.C. 1622(c); Mar. 10, 1950, ch. 54, Sec. 3(c) (as 
     amended by Aug. 9, 1955, ch. 645, Sec. 1); (69 Stat. 562); 
     jointly to the Committees on Foreign Affairs and the 
     Judiciary.

                          ____________________